Skip to content

Clinical Efficacy of Modified Duhuo Jisheng Decoction in Lumbar Disc Herniation: An Exploratory Study on Anti-inflammatory and Neuroprotective Mechanisms

Clinical Efficacy of Modified Duhuo Jisheng Decoction in Lumbar Disc Herniation: An Exploratory Study on Anti-inflammatory and Neuroprotective Mechanisms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000862
Enrollment
Unknown
Registered
2025-04-27
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Interventions

Experimental Group 1:Basic Duhuo Jisheng Decoction only, administered twice daily at a standard dosage for 12 weeks.
Control group:receive standard nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy for 12 weeks.
Experimental Group 2:Based on the Du Huo Ji Sheng Tang basic formula medications will be individualized according to the patients syndrome differentiation. For example for cold-damp type Fu Zi and Gan
for qi stagnation and blood stasis type Dan Shen and Tao Ren will be added
for kidney deficiency type Du Zhong and Xu Duan will be added. Administered twice daily for 12 weeks.

Sponsors

Yan'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1)Age 18-65 years 2)Radiological diagnosis of lumbar disc herniation (MRI or CT) 3)VAS score = 4 4)Signed informed consent form

Exclusion criteria

Exclusion criteria: 1)Pregnant or breastfeeding women 2)Patients with severe cardiovascular or cerebrovascular diseases 3)Recently received other treatments for lumbar disc herniation 4)Individuals allergic to the study medication

Design outcomes

Primary

MeasureTime frame
Pain score (VAS);Oswestry Disability Index (ODI);

Secondary

MeasureTime frame
Quality of life score (EQ-5D);Imaging assessment (MRI intervertebral disc herniation severity);The biomarkers (TNF-a IL-1ß NGF BDNF);

Countries

China

Contacts

Public ContactHe Shiji

Yan'an People's Hospital

ShijiHe2025@163.com15009116865

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026